Agilent - Breakthroughs in Immunotherapy- 2019 - 24
Breakthroughs in Immunotherapy
of BioAnalytical Development at Precision BioSciences. He went
on to explain, "What I like about the NovoCyte Quanteon is that it's
compact, fast and it has accurate volumetric-based cell counting.
It is a robust and stable instrument."
Table 1.
The following are common features cited by users when speaking
about the NovoCyte line of cytometers:
In summary, the Agilent line of NovoCyte cytometers is delivering
in an industry that was already considered too crowded for new
entrants by pushing the boundaries of accessibility and performance. Democratization is at the roots of its appeal and adoption,
especially in the fields of immuno-oncology and immunotherapy.
As flow cytometry continues to drive new applications, especially
in nontraditional workflows such as cell engineering and manufacturing, it must continue to become less complex. The solution
is to make the platforms smarter by being able to configure to
the customer's on-demand expectations and preferences. This is
where Agilent NovoCyte excels. n
1. The wider dynamic range for detecting signals eliminates the
need to adjust PMT voltage. This feature makes data acquisition
simple, especially for new users. Consequentially, this leads to a
reduction in time and mistakes.
References
4. The report function on the NovoExpress software can generate
PDF reports with one click, making data-sharing simple.
1. Picot J, et al: Flow cytometry: retrospective, fundamentals and recent
instrumentation. Cytotechnology. 64 (2): 109-30, 2012
2. Finak G, et al: Standardizing flow cytoanalysis from the human
immunophenotyping consortium. Sci Rep 6: 20686, 2016
3. FloresMontero J, et al: Next generation flow for highly sensitive and
standardized detection of minimal residual disease in multiple myeloma.
Leukemia 31: 20942103, 2017
4. Danova M, et al: The role of automated cytometry in the new era of cancer
immunotherapy. Mol Clin Oncol. 9(4): 355-361, 2018
5. A Quantum Leap In Benchtop Flow Cytometry. (2018) https://go.aceabio.
com/l/492941/2018-12-03/nb13
For Research Use Only. Not for use in diagnostic procedures.
24
| GENengnews.com
2. The NovoCyte has an accurate volumetric-based cell counting
system that performs direct absolute cell counting during data
acquisition without the need for reference counting beads or
extra steps.
3. The NovoExpress software is straightforward and easy to use for
sample acquisition and analysis. Samples can be analyzed with
the same setting by a simple drag-and-drop function, making the
process of data analysis quick and efficient.
5. The groundbreaking fluidics provide pulse-free sample delivery
resulting in higher reproducibility and exceptionally low CVs.
6. The fully automated flow cell wash and shut down features
mitigate flow cell clogging. The system is always ready-to-go for
the next user.
7. Walk-away automation can be achieved with the NovoSampler
Q. This provides superior shaking, even at ultralow volumes, and
accommodates the most popular plate formats, bar coding, and
built-in APIs for lab automation systems .5
https://www.aceabio.com
https://www.aceabio.com
http://www.GENengnews.com
Agilent - Breakthroughs in Immunotherapy- 2019
Table of Contents for the Digital Edition of Agilent - Breakthroughs in Immunotherapy- 2019
Contents
Agilent - Breakthroughs in Immunotherapy- 2019 - 1
Agilent - Breakthroughs in Immunotherapy- 2019 - 2
Agilent - Breakthroughs in Immunotherapy- 2019 - 3
Agilent - Breakthroughs in Immunotherapy- 2019 - Contents
Agilent - Breakthroughs in Immunotherapy- 2019 - 5
Agilent - Breakthroughs in Immunotherapy- 2019 - 6
Agilent - Breakthroughs in Immunotherapy- 2019 - 7
Agilent - Breakthroughs in Immunotherapy- 2019 - 8
Agilent - Breakthroughs in Immunotherapy- 2019 - 9
Agilent - Breakthroughs in Immunotherapy- 2019 - 10
Agilent - Breakthroughs in Immunotherapy- 2019 - 11
Agilent - Breakthroughs in Immunotherapy- 2019 - 12
Agilent - Breakthroughs in Immunotherapy- 2019 - 13
Agilent - Breakthroughs in Immunotherapy- 2019 - 14
Agilent - Breakthroughs in Immunotherapy- 2019 - 15
Agilent - Breakthroughs in Immunotherapy- 2019 - 16
Agilent - Breakthroughs in Immunotherapy- 2019 - 17
Agilent - Breakthroughs in Immunotherapy- 2019 - 18
Agilent - Breakthroughs in Immunotherapy- 2019 - 19
Agilent - Breakthroughs in Immunotherapy- 2019 - 20
Agilent - Breakthroughs in Immunotherapy- 2019 - 21
Agilent - Breakthroughs in Immunotherapy- 2019 - 22
Agilent - Breakthroughs in Immunotherapy- 2019 - 23
Agilent - Breakthroughs in Immunotherapy- 2019 - 24
Agilent - Breakthroughs in Immunotherapy- 2019 - 25
Agilent - Breakthroughs in Immunotherapy- 2019 - 26
Agilent - Breakthroughs in Immunotherapy- 2019 - 27
Agilent - Breakthroughs in Immunotherapy- 2019 - 28
Agilent - Breakthroughs in Immunotherapy- 2019 - 29
Agilent - Breakthroughs in Immunotherapy- 2019 - 30
Agilent - Breakthroughs in Immunotherapy- 2019 - 31
Agilent - Breakthroughs in Immunotherapy- 2019 - 32
Agilent - Breakthroughs in Immunotherapy- 2019 - 33
Agilent - Breakthroughs in Immunotherapy- 2019 - 34
Agilent - Breakthroughs in Immunotherapy- 2019 - 35
Agilent - Breakthroughs in Immunotherapy- 2019 - 36
Agilent - Breakthroughs in Immunotherapy- 2019 - 37
Agilent - Breakthroughs in Immunotherapy- 2019 - 38
Agilent - Breakthroughs in Immunotherapy- 2019 - 39
https://www.nxtbookmedia.com